| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/05/2004 | WO2004029246A3 Integrase cofactor |
| 08/05/2004 | WO2004029023A3 Cell-surface estrogen receptor and related compositions and methods |
| 08/05/2004 | WO2004027019A3 Improved raav expression systems for genetic modification of specific capsid proteins |
| 08/05/2004 | WO2004025302A3 Method for the identification of proteins specific for renal cell carcinoma and use thereof |
| 08/05/2004 | WO2004024077A9 Novel composition and methods for the treatment of psoriasis |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004020465A3 Proteins involved in the regulation of energy homeostasis |
| 08/05/2004 | WO2004009785A3 IgG Fc/HIV-gp120/C3d FUSION PROTEIN |
| 08/05/2004 | WO2004009615A3 Cd40-ligand lacking native-pattern glycosylation |
| 08/05/2004 | WO2004006845A3 Process for producing insoluble and soluble collagen protein products from poultry skins and use thereof |
| 08/05/2004 | WO2004001019A3 Novel nanoparticles and use thereof |
| 08/05/2004 | WO2004000870A3 Two synthetic peptides for treatment and prevention of cancers |
| 08/05/2004 | WO2003104392A3 Improved reagents and methods for producing parvoviruses |
| 08/05/2004 | WO2003102173A8 Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances |
| 08/05/2004 | WO2003102161A3 Methods of diagnosing & treating diabetes and insulin resistance |
| 08/05/2004 | WO2003063581A3 Compositions and methods for increasing animal size and growth rate |
| 08/05/2004 | WO2003060093A3 METHODS AND COMPOSITIONS FOR PROPAGATING VECTORS CONTAINING TOXIC cDNAs AND ION CHANNEL ASSAY SYSTEMS |
| 08/05/2004 | WO2003057899A3 Ion transporter stress-related polypeptides and methods of use in plants |
| 08/05/2004 | WO2003057830A3 Compositions and methods for hydroxylating epothilones |
| 08/05/2004 | WO2003048383A3 Effectors of innate immunity |
| 08/05/2004 | WO2003044185A3 Purified polypeptides involved in general metabolism |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 08/05/2004 | WO2003016553A3 Gpcr-like retinoic acid-induced gene 1 protein and nucleic acid |
| 08/05/2004 | WO2003012063A3 Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof |
| 08/05/2004 | WO2003000038A9 Compositions and methods for modulating plant development |
| 08/05/2004 | WO2002102976A3 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 08/05/2004 | WO2002081731A3 Novel nucleic acids and polypeptides |
| 08/05/2004 | WO2002055548A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 08/05/2004 | US20040154056 Novel molecules of the multi-drug and toxin efflux (MATE) protein family and uses thereof |
| 08/05/2004 | US20040154053 Signal transduction protein involved in plant dehiscence |
| 08/05/2004 | US20040154051 Inducible promoters |
| 08/05/2004 | US20040154049 Compounds |
| 08/05/2004 | US20040154047 Rodent animal model for use in identifying modulators for treatment of familial alzheimer's disease; targeted gene therapy |
| 08/05/2004 | US20040154045 Production of human recombinant collagen in the milk of transgenic animals |
| 08/05/2004 | US20040154044 Transgenic cell and animal modeling ige-mediated human allergic responses and use thereof |
| 08/05/2004 | US20040152885 Lp mammalian proteins; related reagents |
| 08/05/2004 | US20040152884 Methods and materials relating to alpha-2-macroglobulin like polypeptides and polynucleotides |
| 08/05/2004 | US20040152883 Tocopherol associated protein and uses thereof |
| 08/05/2004 | US20040152880 Compositions and methods for the reversible capture of biomolecules |
| 08/05/2004 | US20040152879 Comprises receptor protein associated with osteocyte differentiation for identification of modulators associated with treatment bone and tumor disorders |
| 08/05/2004 | US20040152878 Immunoglobulin which binds alpha helix cytokine for detection of wound healing and cell proliferative agents |
| 08/05/2004 | US20040152877 Comprises polypeptide/nucleoprotein for diagnosis, treatment, and prevention of cell proliferative, developmental, cardiovascular, neurological, and autoimmune/inflammatory disorders |
| 08/05/2004 | US20040152876 Immunogenic HBc chimer particles having enhanced stability |
| 08/05/2004 | US20040152875 Novel purinergic receptor |
| 08/05/2004 | US20040152874 Comprises transport protein for identifying modulators for prevention and treatment of transport, neurological, muscular, immunological, cell proliferative and iron metabolism disorders |
| 08/05/2004 | US20040152873 Novel gene bn01 mapping to chromosone 16q24.3 |
| 08/05/2004 | US20040152871 Comprises nucleotide sequences coding synoviolin polypeptide for identifying modulators for treatment of arthritic and inflammatory disorders |
| 08/05/2004 | US20040152870 Comprises protein on surface of specialized connective tissue for use in identifying modulator for treatments for allergic diseases |
| 08/05/2004 | US20040152658 For therapy of animal having a deficiency in a neuron's immediate early gene responsiveness to a stimulus |
| 08/05/2004 | US20040152653 Administering a pharmacologic complex to the airway epithelium via its luminal surface, wherein the complex comprises a ligand for serpin enzyme complex receptor (SecR) and a pharmacologic agent |
| 08/05/2004 | US20040152650 Reducing BNIP3 expression or activity in the cell for prophylaxis of reducing hypoxia-acidosis induced injury to a cell |
| 08/05/2004 | US20040152637 To assess the risk of individuals to suffer from vascular contraction of coronary arteries in mammals; for therapy of vascular contraction of coronary arteries |
| 08/05/2004 | US20040152636 For therapy of diseases or disorders characterized by undesirable excessive vascularization such as tumors, rheumatoid arthritis, psoriasis, atherosclerosis, diabetic and other retinopathies, retrolental fibroplasia, macular degeneration |
| 08/05/2004 | US20040152635 For blocking the infectiousness of human immunodeficiency virus (HIV) in vivo or in vitro |
| 08/05/2004 | US20040152634 Chemokine antagonists and uses thereof |
| 08/05/2004 | US20040152633 Kunitz-type sequences and polypeptides |
| 08/05/2004 | US20040152630 14-3-3 Binding molecules as sensitizers for anticancer therapies |
| 08/05/2004 | US20040152628 Platelet membrane glycoprotein VI (GPVI) DNA and protein sequences, and uses thereof |
| 08/05/2004 | US20040152624 Oral lactoferrin in the treatment of sepsis |
| 08/05/2004 | US20040152197 Increasing agrobacterium transformation frequencies in maize via propagation in cysteine broth and histone expression |
| 08/05/2004 | US20040152196 Generating immortalized kidney tissues for use in blood detoxification; hemodialysis |
| 08/05/2004 | US20040152191 Using activator glycoprotein to propagate activated macrophages or dendritic cells from monocytes or hematopoietic stem cells for use in treatment of allergic, cell proliferative, autoimmune and infectious disorders |
| 08/05/2004 | US20040152182 Viral particles released after infection by human cytomegalovirus, and their use as vaccine |
| 08/05/2004 | US20040152181 In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents |
| 08/05/2004 | US20040152179 Receptor-mediated uptake of an extracellular Bcl-xL fusion protein inhibits apoptosis |
| 08/05/2004 | US20040152169 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1), monocyte colony inhibitory factor (M-CIF), and macrophage inhibitory factor-4 (MIP-4) |
| 08/05/2004 | US20040152168 Genetically engineered cells comprising expression vectgor coding transcription factor polypeptide for use in transformation of stem cells and generation of pancreatic tissue; insulin delivery tool and diabetes treatment |
| 08/05/2004 | US20040152167 Peptide associated with transcobalamin for use in diagnosis, prevention and treatment of cell prolifefrative disorders |
| 08/05/2004 | US20040152164 62 human secreted proteins |
| 08/05/2004 | US20040152162 Polypeptides capable of interacting with human topoisomerase III alpha |
| 08/05/2004 | US20040152161 Comprises type I membrane protein receptor for identifying modulators for treatment of cell proliferation, leukopenia, anemia, thrombocytopenia, osteoporosis and neurodegenerative disorders |
| 08/05/2004 | US20040152160 Functional splice variant of the alpha7 nicotinic acetylcholine receptor subunit and uses thereof |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152156 Nucleotide sequences coding counter-ligands for several receptors expressed on lymphocytes for use in diagnosis and treatment of asthma, allergic or inflammatory disease |
| 08/05/2004 | US20040152143 Growth differentiation factor-9 |
| 08/05/2004 | US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering |
| 08/05/2004 | US20040152138 Using dementia related osteoponton (DROPN) peptides to diagnose, prognose and identify treatments for progressive neurodegenerative diseases |
| 08/05/2004 | US20040152125 Using nucleic acid hybridization and visual analysis to identify translocations, aneuploidys, large insertions, large deletions, chromosome rearrangement/breaks along chromosome 12q15; diagnosing cancer, asthma and inflammatory disorders |
| 08/05/2004 | US20040152105 Immune modulatory compounds and methods |
| 08/05/2004 | US20040152103 by co-expressing polypeptides using escherichia coli; immunoglobulins; single chain FV fragments; genetic engineering |
| 08/05/2004 | US20040152101 for diagnostic/therapeutic/prophylactics for neurodegenerative diseases, brain dysfunctions, cancers, gastrointestinal/circulatory/endocrine diseases and cell death; genetic engineering |
| 08/05/2004 | US20040152099 for the preparation of a live carrier for the expression of at least one heterologous antigen or of a live vaccine; for in vivo drug screening |
| 08/05/2004 | US20040152098 Cellular signal-responsive gene transcriptional regulation system |
| 08/05/2004 | US20040152093 Genetic engineered polypeptides; hybrids; quantitative analysis |
| 08/05/2004 | US20040152088 Methods for diagnosing and treating heart disease |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040152077 Exonuclease-mediated nucleic acid reassembly in directed evolution |
| 08/05/2004 | US20040152074 Seroreactive regions on HPV 16 proteins E1 and E2 |
| 08/05/2004 | US20040152069 Synthetic gagpol genes and their uses |
| 08/05/2004 | US20040152066 Enhance gene expression; water diffusion or transferring through cell membrane; frozen dough |
| 08/05/2004 | US20040151795 Cast secondary part for electric motors |
| 08/05/2004 | US20040151740 treating strabismus by administering of a neurotoxic component of a botulinum toxin free of a botulinum toxin complex protein. |
| 08/05/2004 | US20040151737 Streptococcal serum opacity factors and fibronectin-binding proteins and peptides thereof for the treatment and detection of streptococcal infection |
| 08/05/2004 | US20040151736 Use of cross-protection to identify novel vaccine candidates for infectious agents |
| 08/05/2004 | US20040151735 immunogenic and vaccine compositions containing HCV envelope peptide and a HCV non-structural peptide, especially a HCV E1 envelope peptide and a HCV NS3 non-structural peptide |
| 08/05/2004 | US20040151728 fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide; antigen bearing target such as viral, bacterial, or fungal cells, parasites or prions |
| 08/05/2004 | US20040151725 nucleic acid encoding a peptide with a CTLA4 extracellular domain and a peptide with an an immunoglobulin constant region; hinge region is modified to reduce complement activation or Fc receptor interaction; immunosuppressants |
| 08/05/2004 | US20040151723 specific to cancerous and precancerous lesions of the uterus |
| 08/05/2004 | US20040151720 Cell surface molecule mediating cell adhesion and signal transmission |